A Translational Research Program for the Development of New Strategies for Immunotherapy Against Cancer
Targeting of cancer neoantigens with donor-derived T cell receptor repertoires.
June 7, 2016 9:49 AM
Johanna Olweus and Ton N. Schumacher publish in Science in collaboration with Fridtjof Lund-Johansen.
JCIT featured in Dagens Medisin discussing the Advance of the Year: Immunotherapy 2.0
July 31, 2017 1:22 PM
In connection with American Society of Clinical Oncology (ASCO) naming immunotherapy as the Society’s advance of the year, Professor Johanna Olweus and Professor Karl-Johan Malmberg was interviewed by Dagens Medisin, April 12th 2017.